Protocols
1 protocol(s) meet the specified criteria
Drug: H3B-6545
Protocol No.TitleStatus
H3B-6545-A001-101A Phase I-II multicenter, open label trial of H3B-6545, a covalent antagonist of estrogen receptor alpha, in women with locally advanced or metastatic estrogen receptor-positive, HER2 negative breast cancerOpen